RxDoctor Payments Data

Renee Whelan

Optometrist · Falmouth, MENPI 1285618355

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,772 of the $5,635 with a category attached, or 84.7%. 22 manufacturers reported payments, led by Alcon at 47.4% of the total. Among optometrist clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,635in general payments, 2019–2025

Across 116 payments — averaging $48.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$3K
  • Coopervision Inc.$599
  • Bausch & Lomb Americas Inc.$433
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$369
  • Kala Pharmaceuticals, Inc.$249
  • AbbVie$221
  • plus $1K from 16 others

What the payments were for

  • Travel & lodging$82115%
  • Food & beverage$4,77285%
  • Gifts$190%
  • Entertainment$220%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,635 in reported general payments places this provider in the 95th percentile of 224 optometrist providers in Maine.

See all optometrist providers in Maine

Medicare billing

Part B allowed, 2024
$28,310
Medicare patients
170
Services billed
1,797

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost99$1,298
Timolol Maleate42$203
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha16$105

Paid to pharmacies, not to this prescriber.

Other optometrist in Falmouth

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →